ASP Isotopes Inc. $ASPI Shares Sold by Telemark Asset Management LLC

Telemark Asset Management LLC cut its stake in ASP Isotopes Inc. (NASDAQ:ASPI) by 37.7% in the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 825,000 shares of the company’s stock after selling 500,000 shares during the period. Telemark Asset Management LLC’s holdings in ASP Isotopes were worth $4,414,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other institutional investors also recently bought and sold shares of ASPI. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. raised its position in ASP Isotopes by 9.4% during the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 31,613 shares of the company’s stock worth $148,000 after buying an additional 2,709 shares during the last quarter. Rhumbline Advisers raised its position in ASP Isotopes by 20.9% during the 2nd quarter. Rhumbline Advisers now owns 78,994 shares of the company’s stock worth $581,000 after buying an additional 13,668 shares during the last quarter. XTX Topco Ltd purchased a new position in ASP Isotopes during the 2nd quarter worth approximately $178,000. New York State Common Retirement Fund raised its position in ASP Isotopes by 418.2% during the 2nd quarter. New York State Common Retirement Fund now owns 17,100 shares of the company’s stock worth $126,000 after buying an additional 13,800 shares during the last quarter. Finally, Invesco Ltd. raised its position in ASP Isotopes by 2,205.0% during the 2nd quarter. Invesco Ltd. now owns 471,219 shares of the company’s stock worth $3,468,000 after buying an additional 450,776 shares during the last quarter. 16.80% of the stock is owned by hedge funds and other institutional investors.

ASP Isotopes Stock Performance

ASPI opened at $6.71 on Friday. ASP Isotopes Inc. has a 12-month low of $3.92 and a 12-month high of $14.49. The company has a current ratio of 4.39, a quick ratio of 4.37 and a debt-to-equity ratio of 0.69. The firm has a market capitalization of $844.79 million, a PE ratio of -3.23 and a beta of 3.42. The firm has a 50 day moving average of $5.54 and a two-hundred day moving average of $5.87.

ASP Isotopes (NASDAQ:ASPI) last posted its earnings results on Wednesday, May 20th. The company reported ($0.22) earnings per share for the quarter, beating the consensus estimate of ($0.28) by $0.06. The firm had revenue of $8.36 million during the quarter, compared to analyst estimates of $3.68 million. ASP Isotopes had a negative net margin of 644.40% and a negative return on equity of 112.46%.

Analyst Ratings Changes

ASPI has been the subject of a number of recent research reports. Weiss Ratings reissued a “sell (d-)” rating on shares of ASP Isotopes in a research report on Friday, March 27th. Canaccord Genuity Group reissued a “buy” rating and set a $11.00 price target on shares of ASP Isotopes in a research report on Tuesday, April 14th. Two research analysts have rated the stock with a Buy rating and one has given a Sell rating to the stock. According to data from MarketBeat, the company has a consensus rating of “Hold” and an average target price of $13.00.

Insider Activity

In other news, CFO Heather Kiessling sold 23,124 shares of ASP Isotopes stock in a transaction that occurred on Wednesday, April 15th. The shares were sold at an average price of $5.48, for a total transaction of $126,719.52. Following the completion of the transaction, the chief financial officer directly owned 709,376 shares of the company’s stock, valued at $3,887,380.48. The trade was a 3.16% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, Director Duncan Moore sold 11,642 shares of ASP Isotopes stock in a transaction that occurred on Thursday, April 16th. The shares were sold at an average price of $5.21, for a total transaction of $60,654.82. Following the transaction, the director directly owned 1,044,928 shares of the company’s stock, valued at approximately $5,444,074.88. This trade represents a 1.10% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold 224,783 shares of company stock valued at $1,648,923 in the last quarter. Company insiders own 14.40% of the company’s stock.

ASP Isotopes Profile

ASP Isotopes Inc, a development stage advanced materials company, focuses on the production, distribution, marketing, and sale of isotopes. It engages in the production and commercialization of Molybdenum-100, a non-radioactive isotope for the medical industry; Carbon-14; and Silicon-28. The company is also developing Quantum Enrichment technology to produce Ytterbium-176, Nickel-64, Lithium 6, Lithium7, and Uranium-235. ASP Isotopes Inc was incorporated in 2021 and is headquartered in Washington, District Of Columbia.